MPM BioVentures I
(BB BioVentures, MPM BioVentures Parallel Fund)
The $230 million MPM BioVentures I family of funds was raised in 1997. The fund is now fully committed with 75% of the investments in biotechnology and 25% in medical devices and other healthcare related fields. The MPM BioVentures I portfolio is comprised of 26 companies with investments ranging from $5-$20 million invested in each portfolio company. Within biotechnology, our investments are split between companies focused on therapeutics and enabling technologies. Roughly 80% of the funds were invested in U.S. companies, 20% in European companies.